1. Dihydropyrimidine dehydrogenase activity: prognostic partner of 5-fluorouracil?;Allegra;Clinical Cancer Research,1999
2. Position statement on care of patients receiving oral anti cancer drugs;British Oncology Pharmacy Association (BOPA);Pharmaceutical Journal,2004
3. First line oral capecitabine therapy in metastatic colorectal cancer: a favourable safety profile compared with intravenous 5-Flourouracil/leucovorin;Cassidy;Annals of Oncology,2002
4. Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer;Cassidy;Journal of Clinical Oncology,2008
5. Cassidy J. Bridgewater J. Maisey N. Raouf S. Glynne-Jones R. Iveson T. Samuel L. 2009 Oral Chemotherapy Practical Guidance: An educational resource developed by UK oncologists for the use of oral chemotherapy in the management of colorectal cancer